1. [Untitled]
- Author
-
Dae-Young Kim, Young Hoon Park, Vibhor Saraswat, and Jeewon Lee
- Subjects
biology ,Bioengineering ,General Medicine ,medicine.disease_cause ,biology.organism_classification ,Applied Microbiology and Biotechnology ,Glucagon ,Enterobacteriaceae ,law.invention ,chemistry.chemical_compound ,Biochemistry ,chemistry ,law ,medicine ,Recombinant DNA ,Yeast extract ,Inducer ,Lactose ,Escherichia coli ,Bacteria ,Biotechnology - Abstract
Using lactose as an inducer, recombinant human interleukin-2 (rhIL-2) was synthesized with an N-terminus fusion partner, G3 (three tandem-arranged glucagon peptides) in fed-batch cultures at high cell concentration (60–90 g l−1) of Escherichia coli BL21(DE3) [pT7-G3IL2]. With batch additions of lactose (4 × 13.5 g), the fusion rhIL-2 was synthesized up to 9.3 g l−1. However, if all the lactose (54 g) was added at once to the culture, synthesized fusion rhIL-2 decreased to 5.4 g l−1 with a decreased cell growth rate. A statistical optimization of the production medium containing glucose, yeast extract, and lactose led to fusion rhIL-2 being produced at > 9 g l−1.
- Published
- 2000
- Full Text
- View/download PDF